Archive: 2012

 

 

Bioscience Managers Announces First Close on New Healthcare Fund

Leading Australasian bioscience fund manager, Octa Phillip Bioscience Managers (Bioscience Managers), today announced a successful first close on its second fund, the Asia Pacific Healthcare Fund II, which has so far attracted $55 million from Australian Institutions, IOOF and MIESF.

Read more about Bioscience Managers Announces First Close on New Healthcare Fund

Australian Bioscience Fund I to invest in Sea Dragon Marine Oils

IB Australian Bioscience Fund I, managed by Octa Phillip Bioscience Managers (OPBM, formerly IB Managers) has today entered into a conditional Subscription Agreement to invest NZD$2.5 million into Claridge Capital...

Read more about Australian Bioscience Fund I to invest in Sea Dragon Marine Oils

Angiotech Founder Joins Union Medtech & Bioscience Managers’ Global Team

Octa Phillip Bioscience Managers provision of management services and support to Union MedTech Plc, the UK listed medical technology investment vehicle, today received a boost with Union Medtech’s announcement of...

Read more about Angiotech Founder Joins Union Medtech & Bioscience Managers’ Global Team

Leading Fund Manager Snares Star Analyst

New look Octa Phillip Bioscience Managers (Bioscience Managers – formerly IB Managers) is looking to create an all-star team with the addition of Starmine top rated analyst Dr Graeme Wald as it progresses towards a first close on its second fund.

Read more about Leading Fund Manager Snares Star Analyst